Division of Vascular Surgery, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA.
Surgery. 2011 Oct;150(4):788-95. doi: 10.1016/j.surg.2011.07.061.
Despite advances in endoluminal salvage for failed endografts, certain circumstances necessitate open endovascular abdominal aneurysm repair (EVAR) conversion. We review the indications for and outcomes after late EVAR explants.
Retrospective review of EVAR patients requiring delayed (>30 days) conversion from 1999 to 2009. Demographics, index endovascular procedure, conversion indication/technique, and outcomes were analyzed.
Among 16 patients who required late conversion, the mean age was 73 years (range, 41-84 years) and 94% were men. Indications included 9 device failures, 6 endograft infections, and a single type II endoleak with sac enlargement. Explanted prostheses included the following: 7 Cook Zenith(®) endoprosthesis, 3 Gore Excluder(®) grafts, 3 Medtronic AneuRx(®) endograft devices, 2 Endologix Powerlink(®) endografts, and 1 Guidant Ancure(®) graft. Before conversion, 7 patients underwent unsuccessful secondary salvage procedures. Transperitoneal (81%) and left retroperitoneal approaches (19%) were used, with 75% requiring supraceliac control. Reconstructions depended on clinical manifestations and included 10 in situ prosthetic repairs, 4 extra-anatomic bypasses, and 2 in situ cryopreserved human allograft repairs. Two patients died during their hospitalization, resulting in a 13% mortality rate. Mean hospitalization for survivors was 18 days (range, 6-78 days), and 7 (50%) of the patients were discharged directly home.
Most delayed EVAR conversions are because of device failure or infection and can be successfully converted to open surgical reconstruction. Supraceliac control is often required, and the perioperative complications are greater than primary elective open or endovascular repair. This study addresses how best to manage failed abdominal aortic endografts and what can be done to improve patient outcomes with this difficult clinical problem.
尽管腔内修复术在治疗失败的血管内移植物方面取得了进展,但某些情况下仍需要进行开放血管内腹主动脉瘤修复(EVAR)转换。我们回顾了晚期 EVAR 取出术的适应证和结果。
回顾性分析 1999 年至 2009 年期间需要延迟(>30 天)转换的 EVAR 患者。分析了患者的人口统计学资料、指数血管内手术、转换指征/技术和结果。
在 16 名需要晚期转换的患者中,平均年龄为 73 岁(范围,41-84 岁),94%为男性。适应证包括 9 例器械失败、6 例移植物感染和 1 例单纯 II 型内漏伴囊腔增大。取出的假体包括:7 个 Cook Zenith(®)支架、3 个 Gore Excluder(®)移植物、3 个 Medtronic AneuRx(®)移植物、2 个 Endologix Powerlink(®)移植物和 1 个 Guidant Ancure(®)移植物。在转换之前,7 名患者进行了不成功的二次挽救手术。采用经腹腔(81%)和左腹膜后(19%)入路,75%需要超髂总动脉控制。重建取决于临床表现,包括 10 例原位假体修复、4 例解剖外旁路和 2 例原位冷冻保存的人同种异体修复。2 名患者在住院期间死亡,死亡率为 13%。幸存者的平均住院时间为 18 天(范围,6-78 天),7 名(50%)患者直接出院回家。
大多数晚期 EVAR 转换是由于器械故障或感染所致,可成功转换为开放手术重建。通常需要超髂总动脉控制,围手术期并发症多于原发性择期开放或血管内修复。本研究探讨了如何最好地处理失败的腹主动脉内支架,并探讨了如何通过这一困难的临床问题改善患者的预后。